BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Monday 6 July 2020
BioLargo completes prototype for PFAS treatment system, ready for pilot testing
BioLargo (OTCQB: BLGO) CEO Dennis Calvert Calvert joined Steve Darling from Proactive with news the company has completed manufacturing on its first prototype unit of their patented BioLargo AEC to tackle PFAS contamination.
Calvert told Proactive the next step and he also told investors about a new product from their Clyra Medical called Clyraguard.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment